Fidelity Investments
BCYC

Fidelity Investments’s Bicycle Therapeutics BCYC Stock Holding History

Fidelity Investments’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-316
Closed -$2.24K – 5432
2025
Q4 		$2.24K Hold
316
– – ﹤0.01% 5002
2025
Q3 		$2.45K Hold
316
– – ﹤0.01% 4910
2025
Q2 		$2.2K Hold
316
– – ﹤0.01% 4846
2025
Q1 		$2.68K Hold
316
– – ﹤0.01% 4836
2024
Q4 		$4.42K Sell
316
-150,200
-100% -$3.22M ﹤0.01% 4687
2024
Q3 		$3.41M Buy
+150,516
New +$3.47M ﹤0.01% 2244
2024
Q1 		– Sell
-266,347
Closed -$4.82M – 5367
2023
Q4 		$4.82M Hold
266,347
– – ﹤0.01% 2080
2023
Q3 		$5.35M Sell
266,347
-20,800
-7% -$476K ﹤0.01% 2020
2023
Q2 		$7.33M Hold
287,147
– – ﹤0.01% 1959
2023
Q1 		$6.11M Sell
287,147
-90,500
-24% -$2.27M ﹤0.01% 2028
2022
Q4 		$11.2M Sell
377,647
-287,159
-43% -$7.7M ﹤0.01% 1841
2022
Q3 		$15.5M Sell
664,806
-43,274
-6% -$1.03M ﹤0.01% 1699
2022
Q2 		$11.9M Sell
708,080
-95,668
-12% -$2.02M ﹤0.01% 1883
2022
Q1 		$35.3M Sell
803,748
-657,134
-45% -$30.7M ﹤0.01% 1542
2021
Q4 		$88.9M Buy
1,460,882
+999,253
+216% +$55.1M 0.01% 1154
2021
Q3 		$19.2M Buy
461,629
+250,185
+118% +$8.75M ﹤0.01% 1866
2021
Q2 		$6.42M Hold
211,444
– – ﹤0.01% 2263
2021
Q1 		$6.32M Hold
211,444
– – ﹤0.01% 2188
2020
Q4 		$3.79M Hold
211,444
– – ﹤0.01% 2248
2020
Q3 		$4.03M Hold
211,444
– – ﹤0.01% 2136
2020
Q2 		$3.28M Buy
+211,444
New +$3.25M ﹤0.01% 2169

Other funds holding BCYC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments's BCYC Position: Q1 2026 in Review

Fidelity Investments sold out of Bicycle Therapeutics (BCYC) in Q1 2026, closing a stake of 316 shares — an estimated $2.24K sold.

Fidelity Investments first reported a position in BCYC in Q2 2020 and held it in 21 quarters. The position peaked at $88.9M in Q4 2021. 98 funds tracked by Wall St. Rank hold BCYC as of Q1 2026.

  • Fidelity Investments reported no remaining Bicycle Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Fidelity Investments sold 316 Bicycle Therapeutics shares in Q1 2026, an estimated $2.24K.
  • Fidelity Investments first reported a position in Bicycle Therapeutics in Q2 2020 and held it in 21 quarters.
  • Fidelity Investments's Bicycle Therapeutics position peaked at $88.9M in Q4 2021.
  • 98 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.